ArthroCare to pay $74M to settle class action

ArthroCare ($ARTC) has reached an agreement to settle private securities class action suits pending against it and two former officers for $74 million. The agreement would settle all claims arising from the purchase or sale of ArthroCare securities and common stock between Dec. 11, 2007, and Feb. 18, 2009. ArthroCare release

Suggested Articles

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.

The FDA launched a center of excellence to oversee digital health products such as smartphone apps, wearable devices and software-based treatments.

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.